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Background and Objective. We examined the association of elevated ankle blood pressure (ABP), together with exercise blood
pressure, with incident cerebrovascular (CV) morbidity and mortality in a prospective follow-up study of 3,808 patients. The
results were compared with pulse pressure, another indicator of arterial stiﬀness. Methods. Patients with normal ankle and exercise
brachial blood pressures were taken as the reference group. Pulse pressure was considered as quartiles with the lowest quartile as
the reference category. Results. A total of 170 subjects had a CV event during the follow-up. Multivariate adjusted hazard ratio of
a CV event was 2.24 (95% CI 1.43–3.52, P<. 0001) in patients with abnormal ABP. The pulse pressure was signiﬁcant only in
the model adjusted for age and sex. Conclusion. The risk of a future CV event was elevated already in those patients among whom
elevated ABP was the only abnormal ﬁnding. As a risk marker, ABP is superior to the pulse pressure.
1.Introduction
High ankle blood pressure (ABP) might be an emerging
risk marker for early subclinical damage of arterial vessels
evaluated as elevated ankle blood pressure alone [1, 2]o r
in conjunction with the elevated ankle brachial index (ABI)
[3–5]. The high ABP or high ABI provides an indication of
arterial stiﬀness or atherosclerosis of the vessel wall whereas
the low ankle pressure or low ABI is indicative of advanced
atherosclerosis, which has reached the point where the blood
ﬂow is impeded. Several studies have demonstrated that
there is a nonlinear, U-shaped association between the ankle
brachial index and total mortality or cardiovascular events
[4–10]. On the other hand, while the normal ABI does
not exclude signiﬁcant peripheral arterial disease [6, 11, 12]
the ABP alone could be useful in evaluating early vascular
changes.
The pulse pressure (PP) has been used as a crude indi-
cator of arterial stiﬀness [13–17]. The increased PP predicts
dementia [18] and cardiovascular mortality [15], acting
more on coronary than cerebrovascular (CV) vessels [19].
In hypertensive subjects with high PP, stroke mortality is
increased [20, 21]. In many recently published papers the
centralPPismorecloselyrelatedtovasculardamagethanthe
peripheral PP [13, 22–26], and the peripheral pressure does
not necessarily accurately reﬂect the central pressure. The
diﬀerence between central and peripheral PP is dependent
on age, height, and heart rate making the evaluation of aortic
pulse pressure from a peripheral pulse pressure diﬃcult.
Elevated ABP may provide a pivotal opportunity to
identify persons at high risk of stroke or TIA. Accordingly,
the main aim of the present study was to assess the utility
of ABP, together with exercise brachial BP, as a predictor
of CV events in a prospective setting. The second aim was
to investigate whether the elevated ABP predicts CV events
better than the pulse pressure. Both measurements reﬂect
aortic stiﬀness. We hypothesized that the ABP would be
superior to the pulse pressure for screening purposes.2 Stroke Research and Treatment
2.MaterialandMethods
This prospective follow-up study was initiated in August
1989. The methods of baseline data collection have been
d e s c r i b e di no u rp r e v i o u sp a p e r[ 1]. The subjects were
derived from a group of 4,038 consecutive ambulatory
patients who underwent a symptom-limited bicycle exercise
test at the Deaconess Institute between August 1989 and
December 1995. Patients with a history of cardiovascular
disease (including those with a history of cerebrovascular
events) at baseline investigation were excluded from the
analyses, and the ﬁnal study group consisted of 3,808
patients. The study was approved by the Ethical Committee
of the National Public Health Institute of Finland.
The ankle and brachial blood pressures were obtained
simultaneously after a 5min rest in supine position using the
Doppler sonography for the ABP and the standard mercury
sphygmomanometer for the left arm blood pressures. Sub-
j e ct sw e r ed i vi d e dt oﬁ v egr o u p sb a s e do nt h eA B Pa tr e s ta n d
exercise blood pressures (EBPs) at a moderate exercise level
(men150Watts,women80Watts)asshownintheﬂowchart
(Figure 1).
The reference group consisted of “normal” patients
with normal ABP (<175mmHg) and normal systolic EBP
(≤215mmHg). Group 2 consisted of patients with elevated
ABP (≥175mmHg), but normal EBP. Group 3 had elevated
ABPandexaggeratedEBP(>215mmHg).Patientsingroup4
had elevated EBP, but the ABP was normal. The discrepancy
between the ABP and EBP indicates signiﬁcant atheroscle-
rotic changes in conduit vessels. Group 5, the unclassiﬁable
group, consisted of patients, who could not tolerate the
moderate exercise level.
The follow-up was 16 years, until the end of 2007
using record linkage of the study data with the National
Hospital Discharge Register and the National Causes of
Death Register. The endpoint was a major CV event, that
is, death due to CV, nonfatal stoke, or a transient ischemic
attack (TIA). The 9th (until 31.12.1995) and 10th versions
of the International Classiﬁcation of Diseases (ICD-9 and
ICD-10) were used for coding of causes of death and
hospitalizations. We took as CV events the ICD-9 codes 431,
436,4330A,4331A,4339A,4340A,4341A,4349A,and435or
the ICD-10 codes I61, I63-I64. G45. These registers cover all
deaths and hospitalizations in Finland. Thus, the coverage of
follow-up was 100% for symptomatic stroke events leading
to hospitalization or death in Finland. It is however likely
that all TIAs have not been hospitalized and those treated
on an ambulatory basis are not identiﬁed as CV events in
the present study. Altogether, 170 CV events were observed
during the follow-up. Of them, 31 were fatal. As a whole, the
study consisted of 53,044 person-years of followup.
2.1. Statistics. Data are expressed as mean ± SD for con-
tinuous variables or counts and proportions for categorical
variables. The following cardiovascular risk factors were
dichotomized: early parental cardiovascular death (yes or
no), self-reported elevated cholesterol (>6mmol/l, yes or
no), self-reported elevated blood glucose (>6mmol/l, yes
or no), and current smoking (yes or no). Age, BMI,
smoking (years, packet/day), and blood pressure (mmHg)
were handled as continuous variables. Student’s t-tests were
used for comparisons of normally distributed variables,
between persons with and without a CV event during the
follow-up. Categorical variables were compared using chi-
square tests.
Associations between the blood pressure groups, and CV
mortality and morbidity (ﬁrst events) were analyzed using
Kaplan-Meier curves and log-rank tests. Cox proportional
hazards models were used for estimating the multivariate-
adjusted independent associations of the blood pressure
groups or the quartiles of pulse pressure with the risk of a
CV event. Results were expressed as hazard ratios (HRs) and
95% conﬁdence intervals (CIs) compared to the “normal”
group or to the lowest quartile of pulse pressure. The basic
modelswereadjustedforageandsex.Thelargermodelswere
further adjusted for BMI, physical working capacity (METs),
selfreportedbloodglucoseandcholesterol,currentsmoking,
resting brachial systolic blood pressure, and early parental
historyofcardiovasculardisease.Thestatisticalanalyseswere
carried out with R (Version 2.11.1).
3. Results
Baseline characteristics of the study participants are outlined
in Table 1, stratiﬁed by the CV event. A total of 170 subjects
developed a CV event (30 TIAs, 109 nonfatal strokes and
31 fatal strokes) during the follow-up. The patients with a
CV event were older and the blood pressures were higher. In
patients without a CV event almost all other risk factors were
more favorable compared with the CV event group.
Figure 2 shows Kaplan-Meier curves for CV event in
diﬀerent blood pressure groups. The curves diverge continu-
ously and signiﬁcantly (P = .001, log rank test) throughout
the 16 years of follow-up.
The patients with elevated ankle blood pressure with
or without exaggerated exercise blood pressure had 2.6-
2.7-fold risk of a CV event compared with the reference
group in the age- and gender-adjusted model (Table 2). In
the wider model the hazard ratio was 2.2–2.4. In patients
with obstructive changes in leg arteries (Group 4) the risk
of a future CV event was 2.7-fold in the basic model and
2.4-fold in the multivariate adjusted model. The greatest
hazard ratio (7.8 in the basic model and 5.8 in the wider
model) was found in the unclassiﬁable patients (Group 5).
In this group, 55 patients had ABI < 1.0, and 25 patients had
ABI < 0.9.
Pulse pressures in the ﬁve blood pressure groups were
42.7±11,54.4±15,58.5±14,49.0±14,and52.6±16mmHg,
respectively. Correlation between the pulse pressure and the
ankle blood pressure in the blood pressure groups I–III was
high (r2 = 0.48). The correlation was lost, however, when
obstructive changes were observed in the conduit vessels
(Group 4) (r2 = 0.11). The risk of a CV event by quartile
of pulse pressure is shown in Table 3. The reference category
is the lowest quartile of the pulse pressure. Signiﬁcantly
elevated risk for a CV event was found only for the fourth
quartile in the smaller model.Stroke Research and Treatment 3
Reference group
ABP < 175mmHg
EBP ≤ 215mmHg
n = 2169
Group 2
ABP ≥ 175mmHg
EBP ≤ 215mmHg
n = 775
Group 3
ABP ≥ 175mmHg
EBP > 215mmHg
n = 497
Group 4
ABP < 175mmHg
EBP > 215mmHg
n = 215
Group 5
unclassiﬁable
n = 140
All patients
n = 4038
Excluded due to
vascular disease at
baseline, n = 230
Figure 1: A ﬂow-chart describing derivation of the blood pressure groups from all consecutive patients undergoing a clinical exercise test
during the period 1989 to 1995. ABP: ankle blood pressure, EBP: brachial exercise blood pressure at the level of 150 Watts for men and 80
Watts for women.
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Figure 2: Kaplan-Meier curves for cerebrovascular (CV) events according to speciﬁed blood pressure group. Log-rank test for the diﬀerence
between the blood pressure groups: P<. 0001. The numbers indicate people remaining in the follow-up at diﬀerent points in time. The
reference group consists of patients with normal brachial pressure (<140mmHg), ankle blood pressure <175mmHg and exercise blood
pressure ≤215mmHg at the moderate exercise level. Group 2 had elevated ankle blood pressure (≥175mmHg), but normal exercise blood
pressure.Group3had elevated ankle andexercise bloodpressure.Group 4had ankle bloodpressure <175mmHg butelevated exercise blood
pressure (discrepancy), and group 5 could not be classiﬁed because of poor exercise tolerance.
4. Discussion
The main ﬁnding of our study was that ABP, when con-
sidered together with EBP in a physiologically meaningful
way, improved the prediction of incident CV events inde-
pendently of classic risk factors. The healthy group with
normalABPandEBPhadthebestprognosis,whilethegroup
with poor exercise tolerance had clearly the worst prognosis.
For groups II–IV, the Kaplan-Meier curves were overlapping.
Furthermore, ABP was a better predictor than the pulse
pressure. Increased aortic and conduit vessel stiﬀness with
high pressure pulsatility may be the explanation for our4 Stroke Research and Treatment
Table 1: Baseline characteristics of participants with and without incident cerebrovascular event during the follow-up.
No cerebrovascular event Cerebrovascular event ρ
n = 3639 n = 170
Age (years) 50 (10) 57 (10) 0.0001∗
Men/women, n (%) 2423 (67)/1216 (33) 105 (62)/65 (38) NS
Body mass index (kg/m2) 26.1 (4) 26.6 (4) NS
Syst. blood pressure (mmHg) 133 (18) 142 (19) 0.0001∗
Diast. blood pressure (mmHg) 85 (11) 89 (10) 0.0001∗
Pulse/min 74 (13) 74 (12) NS
SBP80 (women) 181 (25) 193 (23) 0.001∗
SBP150 (men) 201 (27) 212 (30) 0.0001∗
SBP Max 203 (28) 205 (29) NS
Ankle blood pressure (mmHg) 165 (27) 174 (34) 0.0001∗
ABI 1.21 (0.2) 1.20 (0.2) NS
Current smokers, n (%) 769 (22) 45 (29) 0.05†
Self-reported abnormal total cholesterol, n (%) 1352 (37) 77 (45%) 0.001†
Self-reported abnormal glucose, n (%) 273 (8) 20 (12) 0.04†
Pos. family history, n (%) 1365 (38) 67 (39) 0.6
METs 7.8 (3) 6.4 (2) 0.0001∗
Blood pressure groups
Group I (reference) 2125 (58%) 44 (26%)
Group II 719 (20%) 56 (33%)
Group III 467 (13%) 30 (18%)
Group IV 214 (6%) 14 (8%)
Group V 114 (3%) 26 (15%) 0.0001†
Data are mean (SD) or n and proportion (%), ∗t-test, †χ2 test.
SBP80: systolic blood pressure at the exercise level of 80 Watts.
SBP150: systolic blood pressure at the exercise level of 150 Watts.
SBPMax: maximum systolic blood pressure during exercise.
ABI: ankle brachial index.
METs: physical working capacity in metabolic equivalents.
Please see Section 2 for the explanation for the blood pressure groups.
Table 2: Hazard ratios (HR, 95% Conﬁdence Interval (CI)) of cerebrovascular events according to the speciﬁed blood pressure groups (total
n = 3808, no of events = 170).
Blood pressure group Model 1 Model 2
HR 95% (CI) P values HR 95% CI P values
G r o u p I 1( R e f e r e n c e ) 1( R e f e r e n c e )
Group II 2.69 1.78–4.07 <.0001 2.24 1.43–3.52 <.0001
Group III 2.60 1.60–4.20 <.0001 2.09 1.21–3.61 .008
Group IV 2.71 1.44–5.10 .002 2.37 1.31–4.69 .007
Group V 7.82 4.67–13.12 <.0001 5.78 3.31–10.10 <.0001
Model 1: adjusted for age and sex.
Model 2: adjusted for age, sex, BMI, resting brachial systolic blood pressure, smoking, early parental cardiovascular disease and physical working capacity
(METs), self-reported elevated cholesterol, and abnormal blood glucose.
Please see Section 2 for the explanation for the blood pressure groups.
ﬁnding. The elevated ABP may be a useful surrogate marker
for central and conduit arterial stiﬀness.
These ﬁndings extend our understanding of the be-
haviour and clinical signiﬁcance of the ABP. In the recent
PARTNER study [4], individuals with high ABI had much
higher systolic blood pressure in the ankle and modestly
lower brachial artery systolic blood pressure compared with
those with normal ABI. The pathophysiologic conditions
causing stiﬀer arteries or stiﬀer surrounding tissues are
insuﬃciently understood. While diabetes and degenerative
vascular changes explain the phenomenon only in part [6],
the increased stiﬀness, central and peripherial, could partly
explain the elevated ABP. Aortic wall stiﬀness increases
throughout the normal human lifespan, particularly in the
presence of cardiovascular disease risk factors, and is ﬁrst
seen in increasing pulse wave velocity and central waveStroke Research and Treatment 5
Table 3: Hazard ratios (HR, 95% Conﬁdence Interval (CI)) of cerebrovascular events by quartile of pulse pressure.
Model 1 Model 2
HR 95% CI P values HR 95% CI P values
Quartile I 1 (Reference) 1 (Reference)
Quartile II 0.91 0.54–1.53 .7 0.92 0.55–1.56 .7
Quartile III 1.28 0.80–2.07 .3 1.21 0.75–1.95 .4
Quartile IV 1.62 1.04–2.65 .03 1.47 0.95–2.33 .08
Model 1: adjusted for age and sex.
Model 2: adjusted for age, sex, BMI, smoking, early parental cardiovascular disease and physical working capacity (METs), self-reported elevated cholesterol,
and abnormal blood glucose.
reﬂection (augmentation) [16, 27–29]. The stiﬀening of
the aorta with minimal stiﬀening in the large peripheral
musculararteriesdecreasesthenormalimpedancemismatch
between the central and peripheral arteries enabling the
transfer of excessive pulsatile energy into the periphery [17,
27]. Further research is needed to unravel the relationship of
ABP to the pulse wave velocity which is a standard measure
of the central aortic stiﬀness.
When the conduit vessels are free of ﬂow limiting
atherosclerotic stenoses, the main determinants of ABP are
systolic blood pressure, enhanced pulse pressure, and local
changes caused by rigidity of the arteries in the lower
extremities. In these conditions, we can draw epidemiologic
conclusions from ABP per se without indexing it to the
brachial systolic pressure. The discrepancy between the ABP
and exercise blood pressure may disclose those patients
among whom stenotic changes along the conduit vessels
decrease the ABP.
The good correlation between PP and ABP is lost when
the stenotic changes limit the ﬂow in the conduit vessels. The
PP as a crude index of central arterial stiﬀness is not only
hampered by age and heart rate but also by ﬂow limiting
atherosclerotic changes in the conduit vessels. That may
explain why the peripheral PP is diﬀerently related to the
risk of CV events in the literature [14–16, 19, 20, 23–26, 30]
and why the peripheral PP has predictive value for ischaemic
stroke also in normotensive patients [19, 31]a m o n gw h o m
the ﬂow limiting atherosclerotic changes are minor.
A strength of our study is the large sample size and the
long follow-up period of 16 years. Also, in Finland the record
linkage to the National Hospital Discharge Register and the
National Causes of Death Register has good accuracy and
coverage [32]. Some limitations should be acknowledged,
however. The persons studied do not represent a random
sample of the general population. The study participants
are better educated and have a higher than average socioe-
conomic position. The ABP was measured from one leg
only. The blood glucose and total cholesterol were self-
reported and only half of the persons knew their glucose
value. The persons without a known abnormal cholesterol
or glucose values were taken as normal. The study was
also limited by the lack of stroke subtyping. However, as
shown by the ICD codes listed in Section 2,w ee x c l u d e d
subarachnoid hemorrhages and included only intracerebral
hemorrhagesandischemicstrokestokeepourmaterialmore
homogenous. Furthermore, since ischemic strokes generally
account for approximately 75%–80% of all strokes, the
overwhelming majority of included strokes were of ischemic
origin.
In conclusion, our results suggest new ideas about sur-
rogate markers of subclinical vascular damage. The elevated
ABP reveals better than PP the early adverse vascular
changes,andthediscrepancybetweenABPandEBPdiscloses
those patients in whom the atherosclerotic changes have
propagated to the arterial lumen causing ﬂow limiting steno-
sis. The ABP measurement may help us to better identify the
patients who have the greatest risk for a CV event.
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